APA

zur Stadt U., Harms D. O., Schlüter S., Jorch N., Spaar H. J., Nürnberger W., Völpel S., Gutjahr P., Schrappe M., Janka G. & Kabisch H. (20001017). [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase]. : Klinische Padiatrie.

Chicago

zur Stadt U, Harms D O, Schlüter S, Jorch N, Spaar H J, Nürnberger W, Völpel S, Gutjahr P, Schrappe M, Janka G and Kabisch H. 20001017. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase]. : Klinische Padiatrie.

Harvard

zur Stadt U., Harms D. O., Schlüter S., Jorch N., Spaar H. J., Nürnberger W., Völpel S., Gutjahr P., Schrappe M., Janka G. and Kabisch H. (20001017). [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase]. : Klinische Padiatrie.

MLA

zur Stadt U, Harms D O, Schlüter S, Jorch N, Spaar H J, Nürnberger W, Völpel S, Gutjahr P, Schrappe M, Janka G and Kabisch H. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase]. : Klinische Padiatrie. 20001017.